Diana S. M. Buist

ORCID: 0000-0001-5408-2804
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Cancer Risks and Factors
  • Breast Cancer Treatment Studies
  • Digital Radiography and Breast Imaging
  • AI in cancer detection
  • Colorectal Cancer Screening and Detection
  • Estrogen and related hormone effects
  • BRCA gene mutations in cancer
  • Cervical Cancer and HPV Research
  • Radiomics and Machine Learning in Medical Imaging
  • Breast Lesions and Carcinomas
  • Economic and Financial Impacts of Cancer
  • MRI in cancer diagnosis
  • Health Systems, Economic Evaluations, Quality of Life
  • Radiology practices and education
  • Menopause: Health Impacts and Treatments
  • Medical Imaging Techniques and Applications
  • Cancer survivorship and care
  • Bone health and osteoporosis research
  • Lung Cancer Diagnosis and Treatment
  • Cancer, Lipids, and Metabolism
  • Artificial Intelligence in Healthcare
  • Healthcare cost, quality, practices
  • Advances in Oncology and Radiotherapy
  • Cancer Genomics and Diagnostics

Kaiser Permanente Washington Health Research Institute
2015-2024

Kaiser Permanente
2000-2024

Grail (United States)
2023-2024

Menlo School
2023-2024

University of Washington
2012-2023

University of California, San Francisco
2003-2023

Illumina (United States)
2023

Seattle University
2006-2022

Dartmouth College
2009-2021

University of Vermont
2003-2021

After the US Food and Drug Administration (FDA) approved computer-aided detection (CAD) for mammography in 1998, Centers Medicare Medicaid Services (CMS) provided increased payment 2002, CAD technology disseminated rapidly. Despite sparse evidence that improves accuracy of mammographic interpretations costs over $400 million a year, is currently used most screening mammograms United States.To measure performance digital with without community practice.We compared interpreted (n = 495 818) vs...

10.1001/jamainternmed.2015.5231 article EN JAMA Internal Medicine 2015-09-28

Purpose To establish performance benchmarks for modern screening digital mammography and assess trends over time in U.S. community practice. Materials Methods This HIPAA-compliant, institutional review board–approved study measured the of interpreted by 359 radiologists across 95 facilities six Breast Cancer Surveillance Consortium (BCSC) registries. The included 1 682 504 mammograms performed between 2007 2013 792 808 women. Performance measures were calculated according to American College...

10.1148/radiol.2016161174 article EN Radiology 2016-12-05

Risk prediction models for breast cancer can be improved by the addition of recently identified risk factors, including density and use hormone therapy. We used prospective information to predict a diagnosis in cohort 1 million women undergoing screening mammography.There were 2,392,998 eligible mammograms from without previously diagnosed who had prior mammogram preceding 5 years. Within year mammogram, 11,638 with cancer. Separate logistic regression constructed premenopausal...

10.1093/jnci/djj331 article EN JNCI Journal of the National Cancer Institute 2006-09-05

<h3>Importance</h3> Mammography screening currently relies on subjective human interpretation. Artificial intelligence (AI) advances could be used to increase mammography accuracy by reducing missed cancers and false positives. <h3>Objective</h3> To evaluate whether AI can overcome interpretation limitations with a rigorous, unbiased evaluation of machine learning algorithms. <h3>Design, Setting, Participants</h3> In this diagnostic study conducted between September 2016 November 2017, an...

10.1001/jamanetworkopen.2020.0265 article EN cc-by-nc-nd JAMA Network Open 2020-03-02

Purpose: To retrospectively evaluate the range of performance outcomes radiologist in an audit screening mammography by using a representative sample U.S. radiologists to allow development benchmarks for mammography. Materials and Methods: Institutional review board approval was obtained, study HIPAA compliant. Informed consent or not obtained according institutional guidelines. Data from 188 mammographic facilities 807 between 1996 2002 were analyzed six registries Breast Cancer...

10.1148/radiol.2411051504 article EN Radiology 2006-10-01

Five years of adjuvant tamoxifen therapy for estrogen receptor (ER) -positive breast cancer is more effective than 2 use. However, information on discontinuation scanty. We sought to identify predictors among older women with cancer.Within six health care delivery systems, we identified >or= 65 old diagnosed stage I IIB ER-positive or indeterminant between 1990 and 1994 who had filled a prescription tamoxifen. observed them 5 after initial prescription. used automated pharmacy records...

10.1200/jco.2006.10.1022 article EN Journal of Clinical Oncology 2007-12-11

Accurate long-term breast cancer risk assessment for women attending routine screening could help reduce the disease burden and intervention-associated harms by personalizing recommendations preventive interventions.

10.1001/jamaoncol.2018.0174 article EN cc-by JAMA Oncology 2018-04-06

Background Although several clinical breast cancer risk models are used to guide screening and prevention, they have only moderate discrimination. Purpose To compare selected existing mammography artificial intelligence (AI) algorithms the Breast Cancer Surveillance Consortium (BCSC) model for prediction of 5-year risk. Materials Methods This retrospective case-cohort study included data in women with a negative mammographic examination (no visible evidence cancer) 2016, who were followed...

10.1148/radiol.222733 article EN Radiology 2023-06-01

Background: Younger women (40–49 years) have lower mammographic sensitivity (i.e., greater proportion of cancers detected after a negative mammogram) than older (≥50 years). We explored the effect tumor growth rate, breast density, image quality, and cancer risk factors on in younger women. Methods: studied 576 (n = 73 aged 40–49 years n 503 50 or older) who were diagnosed with invasive between 1988 1993. Interval defined as those within 12 24 months screening mammogram before subsequent...

10.1093/jnci/djh269 article EN JNCI Journal of the National Cancer Institute 2004-10-05

BackgroundWhether a change over time in clinically measured mammographic breast density influences cancer risk is unknown.

10.1093/jnci/djk066 article EN JNCI Journal of the National Cancer Institute 2007-03-06

To identify radiologists' characteristics associated with interpretive performance in screening mammography.The study was approved by institutional review boards of University Washington (Seattle, Wash) and institutions at seven Breast Cancer Surveillance Consortium sites, informed consent obtained, procedures were HIPAA compliant. Radiologists who interpreted mammograms U.S. regions completed a self-administered mailed survey; information on demographics, practice type, experience...

10.1148/radiol.2533082308 article EN Radiology 2009-10-29

Purpose We determined whether the association between breast density and cancer risk severity differs according to menopausal status postmenopausal hormone therapy (HT) use. Methods collected data on 587,369 women who underwent 1,349,027 screening mammography examinations; 14,090 were diagnosed with cancer. calculated 5-year from a survival model for subgroups of classified by their Breast Imaging Reporting Data System (BIRADS) density, age, status, current HT use, assuming body mass index...

10.1200/jco.2009.26.4770 article EN Journal of Clinical Oncology 2010-07-20

In Brief OBJECTIVE: We sought to examine prescribing patterns (prevalence and rates of initiation discontinuation) for estrogen plus progestin (hormone therapy [HT] alone [ET]) in the United States 2 years before published results Women's Health Initiative's (WHI) HT trial's early termination 5 months after their release. METHODS: conducted an observational cohort study 169,586 women aged 40–80 who were enrolled health maintenance organizations estimate prevalence ET discontinuation between...

10.1097/01.aog.0000143826.38439.af article EN Obstetrics and Gynecology 2004-11-01

Chinese translation Background: The effectiveness of screening colonoscopy in average-risk adults is uncertain, particularly for right colon cancer. Objective: To examine the association between and risk incident late-stage colorectal cancer (CRC). Design: Nested case–control study. Setting: Four U.S. health plans. Patients: 1039 enrolled at least 5 years one Case patients were aged 55 to 85 on their diagnosis date (reference date) stage IIB or higher (late-stage) CRC during 2006 2008. One 2...

10.7326/0003-4819-158-5-201303050-00003 article EN Annals of Internal Medicine 2013-03-05

A substantial literature describes age-dependent variations in breast cancer treatment, showing that older women are less likely to receive standard treatment than younger women. We sought identify patient and tumor characteristics associated with the nonreceipt of primary systemic adjuvant therapies.We studied 1,859 age 65 years or stage I II diagnosed between 1990 1994 who were cared for six geographically dispersed community-based health care systems. collected demographic, tumor,...

10.1200/jco.2006.06.3065 article EN Journal of Clinical Oncology 2006-09-18

The increasing availability of electronic health records (EHRs) creates opportunities for automated extraction information from clinical text. We hypothesized that natural language processing (NLP) could substantially reduce the burden manual abstraction in studies examining outcomes, like cancer recurrence, are documented unstructured text, such as progress notes, radiology reports, and pathology reports. developed an NLP-based system using open-source software to process notes 1995 2012...

10.1093/aje/kwt441 article EN American Journal of Epidemiology 2014-01-30

Compared with film, digital mammography has superior sensitivity but lower specificity for women aged 40 to 49 years and dense breasts. Digital replaced film in virtually all US facilities, overall population health cost from use of this technology are unclear. Using five independent models, we compared screening strategies starting at age or 50 applied annually, biennially, based on density biennial ages 74 no screening. Common data elements included cancer incidence test performance, both...

10.1093/jnci/dju092 article EN JNCI Journal of the National Cancer Institute 2014-05-28

Moving to multigene testing for all women with breast cancer (BC) could identify many more mutation carriers who can benefit from precision prevention. However, the cost-effectiveness of this approach remains unaddressed.To estimate incremental lifetime effects, costs, and patients BC compared current practice genetic (BRCA) based on family history (FH) or clinical criteria.This microsimulation modeling study costs effects high-risk BRCA1/BRCA2/PALB2 (multigene) unselected (strategy A)...

10.1001/jamaoncol.2019.3323 article EN cc-by JAMA Oncology 2019-10-03

Breast magnetic resonance imaging (MRI) is highly sensitive for detecting breast cancer. Low specificity, cost, and little evidence regarding mortality benefits, however, limit recommendations its use to high-risk women. How MRI actually used in community settings unknown.To describe trends indications a setting.Retrospective cohort study at not-for-profit health plan multispecialty group medical practice New England of 10,518 women aged 20 years older enrolled the least 1 year who had...

10.1001/jamainternmed.2013.11958 article EN JAMA Internal Medicine 2013-11-19
Coming Soon ...